Sanofi Paid $14.6bn In Rebates In 2020; Net Prices Were Down
US Average Aggregate Net Prices Declined 7.8%
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.
You may also be interested in...
The rise of the biosimilars has been predicted for many years, but the commercial dynamics after complex biologic drugs’ loss of exclusivity suggests that it may not be so straightforward.
In this week's podcast edition of Scrip's Five Must-Know Things, hear about Sanofi’s rebates, Moderna’s business prospects, US views on coronavirus vaccine comparisons, Piot talk about virus variants, and new results for Amgen's asthma drug.
Sanofi said the aggregate US net price of its drugs declined by 11.1% in 2019, while list prices increased 2.9%.